Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice [PDF]
, 1989 Peter J. Murray +2 more
openalex +1 more source
Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis [PDF]
, 1987 Jagjit Singh Dhaliwal, F Y Liew
openalex +1 more source
Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease [PDF]
, 1999 Victor J. Chan +3 more
openalex +2 more sources
Development ofLeishmania majorin the Phlebotomine sandflies,Phlebotomus papatasi(Scopoli) andPhlebotomus langeroni(Nitzulescu) [PDF]
, 1988 M. G. Shehata +4 more
openalex +1 more source
Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes. [PDF]
, 1992 M. Kelleher +2 more
openalex +1 more source
Immunoprotective Leishmania major synthetic T cell epitopes. [PDF]
, 1990 Armando Jardim +4 more
openalex +1 more source
Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses [PDF]
, 1994 Gary S. Nabors, J P Farrell
openalex +1 more source
, 2007 Leishmaniasis is a geographically widespread severe disease, with an increasing incidence of two million cases per year and 350 million people from 88 countries at risk. The causative agents are species of Leishmania, a protozoan flagellate.
Ayala, Francisco J +15 more
core +2 more sources
The major Leishmania donovani chagasi surface glycoprotein in tunicamycin-resistant promastigotes. [PDF]
, 1990 Mary E. Wilson, Kara Hardin
openalex +1 more source